Cite
HARVARD Citation
Alfonso Ross Terres, J. et al. (2015). Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5). BMC cardiovascular disorders. 15 (1), pp. 1-6. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Alfonso Ross Terres, J. et al. (2015). Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5). BMC cardiovascular disorders. 15 (1), pp. 1-6. [Online].